Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sunscreens with UVA II/I absorbers inhibit acute, chronic photodamage -- Schering.

Executive Summary

SUNSCREENS WITH UVA II/I ABSORBERS INHIBIT ACUTE, CHRONIC PHOTODAMAGE, Schering-Plough maintained in Dec. 6 comments to FDA regarding the photochemistry and photobiology of sunscreens. Responding to the public meeting held by FDA Sept. 19-20 ("The Rose Sheet" Sept. 23, p. 12), Coppertone manufacturer Schering-Plough asserts the need for "high SPF broad spectrum sunscreen protection that includes the entire UVA spectrum to reduce photodamage that results from chronic exposure to sunlight."
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS003616

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel